IPO Premiums
IPO calendar
CSCHEMCONListed

Chemcon Speciality Chemicals Limited

Bookbuilding IPO · NSE, BSE

Price band
₹338 - ₹340
Lot size
44 shares
Issue amount
₹318 cr
Total subscription
0×
Current price₹216.56
Listing price ₹731
Watch live price ↗
Opens
21 Sept 2020
Closes
23 Sept 2020
Allotment
29 Sept 2020
Listing
1 Oct 2020

Offer at a glance

Issue overview

Issue size
93,52,940 shares
Face value
₹10 per share
Minimum investment
₹14,872
Fresh issue
₹165 cr
Offer for sale
₹153 cr
Registrar
Link Intime India Private Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,960
Issue type
Bookbuilding IPO
Shares before issue
3,17,77,760
Shares after issue
3,66,30,701

Lot sizes

CategoryLotsSharesAmount
RETAIL144₹14,960
sHNI14616₹2,09,440
bHNI672,948₹10,02,320

Share reservation

Retail35.11%
NII(HNI)15.05%
QIB19.98%

Subscription & GMP

Subscription by category

Total subscribed0×

Missing multiples are calculated from bids and offered shares when available.

QIB113.54×
NIB449.14×
RETAIL41.15×

GMP history

015531022 Dec: ₹310
22 Dec₹31022 Dec

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs63.527,212.24
RETAIL111.644,593.55
NIB47.8521,489.97

Financial performance

Company financials

in Lakhs · Reported periods may include interim results.

Revenue & profitin Lakhs
01,0002,0003,0004,000Mar-17 · Revenue: 899.96Mar-17 · Profit after tax: 28.24Mar-17Mar-18 · Revenue: 1,583.91Mar-18 · Profit after tax: 263.81Mar-18Mar-19 · Revenue: 3,053.26Mar-19 · Profit after tax: 430.41Mar-19Mar-20 · Revenue: 2,660.17Mar-20 · Profit after tax: 488.53Mar-20
RevenueProfit after tax

Company information

Company profile

Chemcon Speciality Chemicals Ltd, incorporated in 1988, is engaged in the manufacturing of specialised chemicals such as HMDS and CMIC, along with oilfield chemicals including calcium bromide, sodium bromide, and zinc bromide, pharma intermediates, silanes, and contract manufacturing services. Pharmaceutical chemicals form the largest part of its revenue, with key customers comprising Hetero Labs, Laurus Labs, Aurobindo Pharma, Lantech Pharmaceuticals, and Macleods Pharma, while in the oilfield chemicals segment it caters to clients like Shree Radha Overseas, Universal Drilling Fluids, and Water Systems Speciality. In 2018, the company ranked as the eighth-largest HMDS manufacturer and the second-largest CMIC manufacturer globally, highlighting its strong market position. Chemcon serves both domestic and international markets, exporting to countries such as the USA, China, Japan, UAE, Serbia, Russia, Malaysia, and Azerbaijan, and operates its manufacturing facility at Manjusar near Vadodara, Gujarat, which includes five production plants, three owned warehouses, and two leased warehouses.

Strengths

  • World's largest producer of pharmaceutical chemicals.
  • India's top manufacturer of oilfield chemicals.
  • Serving customers across India and worldwide.
  • Strong and steady financial growth.
  • Specialized manufacturing plants for each product.

Promoters

KamalKumar Rajendra Aggarwal

Navdeep Naresh Goyal

Shubharangana Goyal

Registrar & documents

Lead manager

Ambit Private Limited, Intensive Fiscal Services Private Limited

Registered office

Block Number 355, Manjusar Kunpad Road Manjusar Village, Taluka Savli Vadodara 391775

91 98795 64107

[email protected]Company website ↗

Understanding CHEMCON IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.